CAMP4 Therapeutics Corp. (CAMP)
4.30
-0.03
(-0.69%)
USD |
NASDAQ |
Nov 11, 12:10
CAMP4 Therapeutics Debt to Equity Ratio : 0.0602 for Sept. 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.0602 |
| June 30, 2026 | -3.423 |
| March 31, 2026 | 0.0687 |
| December 31, 2025 | 0.0414 |
| September 30, 2025 | 0.1082 |
| June 30, 2025 | 0.1806 |
| Date | Value |
|---|---|
| March 31, 2025 | 0.1544 |
| December 31, 2024 | 0.1383 |
| September 30, 2024 | 3.039 |
| June 30, 2024 | 0.6997 |
| March 31, 2024 | |
| December 31, 2023 | 0.3171 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0518 |
| Alnylam Pharmaceuticals, Inc. | 0.8316 |
| Anika Therapeutics, Inc. | 0.1901 |
| Savara, Inc. | 0.2815 |
| Vericel Corp. | 0.241 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 134.01M |
| Total Liabilities (Quarterly) | 26.92M |
| Shareholders Equity (Quarterly) | 107.09M |
| Current Ratio | 6.420 |
| Net Debt Paydown Yield | 0.06% |